HISAMITSU PHARMA. financial statements, including revenue, expenses, profit, and loss

The total revenue of HPX for the last quarter is 245.45 M EUR, and it's 16.95% higher compared to the previous quarter. The net income of Q2 24 is 26.68 M EUR.